MTIM
PFE icon

Marathon Trading Investment Management’s Pfizer PFE Stock Holding History

Marathon Trading Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,800
Closed -$96.8K – 392
2025
Q3 		$96.8K Buy
3,800
+1,800
+90% +$44.4K 0.01% 240
2025
Q2 		$48.5K Sell
2,000
-5,800
-74% -$135K 0.01% 238
2025
Q1 		$198K Buy
7,800
+200
+3% +$5.23K 0.03% 237
2024
Q4 		$202K Sell
7,600
-2,400
-24% -$65.1K 0.01% 210
2024
Q3 		$289K Buy
10,000
+9,900
+9,900% +$289K 0.03% 186
2024
Q2 		$2.8K Sell
100
-1,100
-92% -$30.3K ﹤0.01% 279
2024
Q1 		$33.3K Sell
1,200
-62,000
-98% -$1.72M ﹤0.01% 318
2023
Q4 		$1.82M Buy
63,200
+19,300
+44% +$583K 0.09% 111
2023
Q3 		$1.46M Buy
43,900
+17,700
+68% +$626K 0.12% 87
2023
Q2 		$961K Buy
26,200
+16,800
+179% +$654K 0.08% 99
2023
Q1 		$384K Sell
9,400
-4,400
-32% -$190K 0.03% 144
2022
Q4 		$707K Buy
+13,800
New +$662K 0.09% 118
2022
Q3 		– Sell
-4,000
Closed -$210K – 307
2022
Q2 		$210K Sell
4,000
-8,500
-68% -$433K 0.02% 217
2022
Q1 		$647K Buy
+12,500
New +$649K 0.06% 158
2021
Q1 		– Sell
-23,300
Closed -$858K – 478
2020
Q4 		$858K Buy
+23,300
New +$855K 0.04% 170
2019
Q2 		– Sell
-26,350
Closed -$1.06M – 273
2019
Q1 		$1.06M Buy
+26,350
New +$1.06M 0.12% 128
2015
Q2 		– Sell
-21,080
Closed -$696K – 521
2015
Q1 		$696K Sell
21,080
-350,982
-94% -$11.2M 0.04% 299
2014
Q4 		$10.9M Hold
372,062
– – 0.16% 85
2014
Q3 		$10.3M Sell
372,062
-8,327
-2% -$234K 0.28% 52
2014
Q2 		$10.4M Buy
+380,389
New +$10.8M 0.35% 41
2013
Q3 		– Sell
-210,800
Closed -$5.6M – 169
2013
Q2 		$5.6M Buy
+210,800
New +$5.82M 0.38% 23

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Marathon Trading Investment Management's PFE Position: Q3 2025 in Review

Marathon Trading Investment Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 17,880 shares — an estimated $441K sold.

Marathon Trading Investment Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $4.8M in Q4 2023. 2,814 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Marathon Trading Investment Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Marathon Trading Investment Management sold 17,880 Pfizer shares in Q3 2025, an estimated $441K.
  • Marathon Trading Investment Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
  • Marathon Trading Investment Management's Pfizer position peaked at $4.8M in Q4 2023.
  • 2,814 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Marathon Trading Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.